Health Loss Due To Market Access Delays And Reimbursement Restrictions In First-Line EGFR-Positive Non-Small Cell Lung Cancer In The EU5 Countries
Abstract
Authors
K van Nimwegen K Nientker S Boukouvalas
K van Nimwegen K Nientker S Boukouvalas
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now